Circulating Biomarkers of Cardiac Fibrosis-Reference-Cited by-同舟云学术

Circulating Biomarkers of Cardiac Fibrosis

Published:2017-03 Issue:3 Volume:10 Page:
ISSN:1941-3289
Container-title:Circulation: Heart Failure
language:en
Short-container-title:Circ: Heart Failure

Author:

Richards A. Mark¹

Affiliation:

1. From the Cardiovascular Research Institute, National University Heart Centre, Singapore; and Christchurch Heart Institute, University of Otago, Dunedin, New Zealand.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/CIRCHEARTFAILURE.117.003936

Reference20 articles.

1. Circulating Biomarkers of Myocardial Fibrosis

2. Collagen Cross-Linking But Not Collagen Amount Associates With Elevated Filling Pressures in Hypertensive Patients With Stage C Heart Failure

3. Losartan-Dependent Regression of Myocardial Fibrosis Is Associated With Reduction of Left Ventricular Chamber Stiffness in Hypertensive Patients

4. Mineralocorticoid Receptor Antagonism Ameliorates Left Ventricular Diastolic Dysfunction and Myocardial Fibrosis in Mildly Symptomatic Patients With Idiopathic Dilated Cardiomyopathy

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular and molecular mechanisms driving cardiac tissue fibrosis: On the precipice of personalized and precision medicine;Cardiovascular Pathology;2024-07

2. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study;Joint Bone Spine;2024-05

3. Defining cardiac fibrosis complexity and regulation towards therapeutic development;Clinical and Translational Discovery;2023-01

4. Simple Predictors for Cardiac Fibrosis in Patients with Type 2 Diabetes Mellitus: The Role of Circulating Biomarkers and Pulse Wave Velocity;Journal of Clinical Medicine;2022-05-18

5. Effects of Sacubitril/Valsartan on biomarkers of fibrosis and inflammation in patients with heart failure with reduced ejection fraction;BMC Cardiovascular Disorders;2022-05-13